Puig T - Search Results

1

Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.

Puig T, Relat J, Marrero PF, Haro D, Brunet J, Colomer R. Puig T, et al. Anticancer Res. 2008 Nov-Dec;28(6A):3671-6. Anticancer Res. 2008. PMID: 19189648

2

(-)-Epigallocatechin-3-Gallate Antihyperalgesic Effect Associates With Reduced CX3CL1 Chemokine Expression in Spinal Cord.

Bosch-Mola M, Homs J, Álvarez-Pérez B, Puig T, Reina F, Verdú E, Boadas-Vaello P. Bosch-Mola M, et al. Among authors: puig t. Phytother Res. 2017 Feb;31(2):340-344. doi: 10.1002/ptr.5753. Epub 2016 Nov 29. Phytother Res. 2017. PMID: 27896922

3

Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients.

Porta R, Blancafort A, Casòliva G, Casas M, Dorca J, Buxo M, Viñas G, Oliveras G, Puig T. Porta R, et al. Among authors: puig t. Menopause. 2014 Feb;21(2):188-91. doi: 10.1097/GME.0b013e31829d17dc. Menopause. 2014. PMID: 23982110

4

Circulating Fatty Acid Synthase in pregnant women: Relationship to blood pressure, maternal metabolism and newborn parameters.

Carreras-Badosa G, Prats-Puig A, Puig T, Vázquez-Ruíz M, Bruel M, Mendoza E, de Zegher F, Ibáñez L, López-Bermejo A, Bassols J. Carreras-Badosa G, et al. Among authors: puig t. Sci Rep. 2016 Apr 19;6:24167. doi: 10.1038/srep24167. Sci Rep. 2016. PMID: 27090298 Free PMC article.

5

Antimicrobial cyclic decapeptides with anticancer activity.

Feliu L, Oliveras G, Cirac AD, Besalú E, Rosés C, Colomer R, Bardají E, Planas M, Puig T. Feliu L, et al. Among authors: puig t. Peptides. 2010 Nov;31(11):2017-26. doi: 10.1016/j.peptides.2010.07.027. Epub 2010 Aug 11. Peptides. 2010. PMID: 20708052

6

Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.

Xifró X, Vidal-Sancho L, Boadas-Vaello P, Turrado C, Alberch J, Puig T, Verdú E. Xifró X, et al. Among authors: puig t. PLoS One. 2015 Apr 9;10(4):e0123122. doi: 10.1371/journal.pone.0123122. eCollection 2015. PLoS One. 2015. PMID: 25855977 Free PMC article.

7

Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.

Blancafort A, Giró-Perafita A, Oliveras G, Palomeras S, Turrado C, Campuzano Ò, Carrión-Salip D, Massaguer A, Brugada R, Palafox M, Gómez-Miragaya J, González-Suárez E, Puig T. Blancafort A, et al. Among authors: puig t. PLoS One. 2015 Jun 24;10(6):e0131241. doi: 10.1371/journal.pone.0131241. eCollection 2015. PLoS One. 2015. PMID: 26107737 Free PMC article.

8

Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer.

Giró-Perafita A, Palomeras S, Lum DH, Blancafort A, Viñas G, Oliveras G, Pérez-Bueno F, Sarrats A, Welm AL, Puig T. Giró-Perafita A, et al. Among authors: puig t. Clin Cancer Res. 2016 Sep 15;22(18):4687-97. doi: 10.1158/1078-0432.CCR-15-3133. Epub 2016 Apr 22. Clin Cancer Res. 2016. PMID: 27106068

9

Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.

Colomer R, Sarrats A, Lupu R, Puig T. Colomer R, et al. Among authors: puig t. Curr Drug Targets. 2017;18(2):147-159. doi: 10.2174/1389450117666160112113930. Curr Drug Targets. 2017. PMID: 26758667 Review.

10

Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.

Relat J, Blancafort A, Oliveras G, Cufí S, Haro D, Marrero PF, Puig T. Relat J, et al. Among authors: puig t. BMC Cancer. 2012 Jul 6;12:280. doi: 10.1186/1471-2407-12-280. BMC Cancer. 2012. PMID: 22769244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results